🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours

Recruitingn/aAges 18 Years - 80 YearsAllThe University of Western Australia
NCT06951659 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neuroimaging analysis, of a neurosurgical cohort of patients with brain tumours. This prospective observational cohort study will investigate clinical and neuroimaging characteristics and the relationship between lateropulsion and visual verticality disorder in patients pre- and post-brain tumour resection. Patients (aged 18-80 years, with a confirmed diagnosis of brain tumour and a neurosurgical pathway) will be enrolled from the state-wide Neurosurgery Service of Western Australia at Sir Charles Gairdner Hospital.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients of age 18 to 80 admitted to SCGH under the neurosurgery team with a confirmed diagnosis of a brain tumour. * Only patients who undergo partial or full brain tumour resection and are medically stable. * Able to provide written informed consent or consent provided by a Research Decision-Maker with the approval of an Independent Medical Practitioner (IMP) as per the Guardianship and Administration Act 1990 (GAA). * Patients with a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required. Exclusion Criteria: * Patients who undergo only biopsy will not be included. * Unable to follow any instructions and complete assessments due to significant medical deterioration. * Patients who are pregnant. * Current diagnosis of COVID-19 or respiratory syncytial virus (RSV), or any type of influenza. * Patients without a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required. * An Advanced Care Health Directive prohibiting decision making by Research Decision-Maker.
💊

What it tests

  • Not listed
📍

Where

1 site
Sir Charles Gairdner Osborne Park Health Care Group
Perth, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy